Estrella Immunopharma, Inc
Fundamentals
Oldest to newest| Line | Dec 2022 | Jun 2023 | Jun 2024 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating income | −$1.6M | −$11.1M | −$7.3M | −$13.1M | none on file |
| Net income | −$996,104 | −$11.1M | −$7.3M | −$13.1M | none on file |
| Operating cash flow | −$1.0M | −$1.3M | −$16.1M | −$1.8M | none on file |
| Cash | $40,802 | $2.5M | $4.2M | $1.4M | $100,000 |
| Shares outstanding | 1.4M | 978.2K | 36.6M | 38.5M | 43.5M |